Abstract
Bacteria commonly communicate with each other by a cell-to-cell signaling mechanism known as quorum sensing, using soluble mediators. Recent studies showed that these molecules target not only bacteria, but also interact with the eukaryotic host. Pseudomonas aeruginosa infection occurs both in acute or chronic states in a variety of respiratory and urinary infections. These infections are often difficult to treat, and numerous therapeutic options, besides antibiotics, have been searched. In this context quorum-sensing inhibitors could represent an attractive potential therapeutic strategy with promising results.
Keywords: Autoinducers, Host-pathogen relationship, Immunomodulation, Inter-kingdom communication, Pseudomonas aeruginosa, Quorum sensing
Current Organic Chemistry
Title:Pseudomonas aeruginosa -Eukaryotic Cell Crosstalk: Mediators, Mechanisms and Implications for the Antimicrobial Therapy
Volume: 17 Issue: 2
Author(s): Carmen Curutiu, Mariana Carmen Chifiriuc and Magda Mihaela Mitache
Affiliation:
Keywords: Autoinducers, Host-pathogen relationship, Immunomodulation, Inter-kingdom communication, Pseudomonas aeruginosa, Quorum sensing
Abstract: Bacteria commonly communicate with each other by a cell-to-cell signaling mechanism known as quorum sensing, using soluble mediators. Recent studies showed that these molecules target not only bacteria, but also interact with the eukaryotic host. Pseudomonas aeruginosa infection occurs both in acute or chronic states in a variety of respiratory and urinary infections. These infections are often difficult to treat, and numerous therapeutic options, besides antibiotics, have been searched. In this context quorum-sensing inhibitors could represent an attractive potential therapeutic strategy with promising results.
Export Options
About this article
Cite this article as:
Curutiu Carmen, Carmen Chifiriuc Mariana and Mihaela Mitache Magda, Pseudomonas aeruginosa -Eukaryotic Cell Crosstalk: Mediators, Mechanisms and Implications for the Antimicrobial Therapy, Current Organic Chemistry 2013; 17 (2) . https://dx.doi.org/10.2174/1385272811317020011
DOI https://dx.doi.org/10.2174/1385272811317020011 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Clinical Determination of the Severity of Metabolic Syndrome: Preheparin Lipoprotein Lipase Mass as a New Marker of Metabolic Syndrome
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Statin Therapy-Evidence Beyond Lipid Lowering Contributing to Plaque Stability
Current Medicinal Chemistry Glucocorticoids, the Etiology of Obesity and the Metabolic Syndrome
Current Alzheimer Research Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery The Soluble CTLA-4 Receptor and its Emerging Role in Autoimmune Diseases
Current Immunology Reviews (Discontinued) The Vascular Wall and the Haemostatic Balance in Type 1 Diabetic Patients with Nephropathy
Vascular Disease Prevention (Discontinued) Implementation of Cardiovascular Disease Prevention Guidelines into Clinical Practice: an Unmet Challenge?
Current Pharmaceutical Design Remediation of Cellular Hypoxic Damage by Pharmacological Agents
Current Pharmaceutical Design Pleiotropic, Cardioprotective Effects of Omega-3 Polyunsaturated Fatty Acids
Mini-Reviews in Medicinal Chemistry Minimising the Effects of Isobaric Product Ions in SIFT-MS Quantification of Acetaldehyde, Dimethyl Sulphide and Carbon Dioxide
Current Analytical Chemistry Anti-Oxidant Gene Therapy by NFkB Decoy Oligodeoxynucleotide
Current Pharmaceutical Biotechnology Immunomodulation in Inflammatory Neuropathies: Rationale and Safety
Current Drug Safety Independent Relationship of Osteocalcin Circulating Levels with Obesity, Type 2 Diabetes, Hypertension, and HDL Cholesterol
Endocrine, Metabolic & Immune Disorders - Drug Targets Contemporary Management of Hypertension - How to Optimize Therapy
Cardiovascular & Hematological Disorders-Drug Targets Sympathetic Activation in Congestive Heart Failure: Evidence, Consequences and Therapeutic Implications
Current Vascular Pharmacology Therapeutic Targets for the Management of Peripheral Nerve Injury- Induced Neuropathic Pain
CNS & Neurological Disorders - Drug Targets Stem Cells in Stroke Repair: Current Success & Future Prospects
CNS & Neurological Disorders - Drug Targets The Role of C-Reactive Protein in Atherosclerotic Cardiovascular Disease: An Overview
Current Vascular Pharmacology Intravitreal Anti-VEGF Drugs as Adjuvant Therapy in Diabetic Retinopathy Surgery
Current Diabetes Reviews Potential Therapeutic Targeting of Platelet-Mediated Cellular Interactions in Atherosclerosis and Inflammation
Current Medicinal Chemistry